Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,109,329 papers from all fields of science
Search
Sign In
Create Free Account
Melanogrammus aeglefinus Ab.IgG:ACnc:Pt:Ser:Qn
Known as:
Melanogrammus aeglefinus Anticorps. IgG:Concentration arbitraire:Temps ponctuel:Sérum:Quantitatif
, Kilttursk antikehad.IgG:Acnc:Pt:S:Qn
, Melanogrammus aeglefinus As.IgG:Arbitraire concentratie:Moment:Serum:Kwantitatief
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
ACnc
Antibodies
Hypersensitivity
Immunoglobulin G
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Using catch statistics to investigate effects of seismic activity on fish catch rates.
A. Vold
,
S. Løkkeborg
,
Maria Tenningen
Advances in Experimental Medicine and Biology
2012
Corpus ID: 8284010
Norway has been a petroleum nation for several decades, with most of its offshore activities originally concentrated in the North…
Expand
2006
2006
Survival and injuries of cod, haddock and saithe that escape through codends and sorting grids in a commercial fishery
Ó. Ingólfsson
,
A. V. Soldal
,
Irene Huse
2006
Corpus ID: 55165296
This is a preprint of an article submitted for consideration in Fisheries Research, Copyright 2006, Elsevier. Fisheries Research…
Expand
Highly Cited
2001
Highly Cited
2001
Lipovitellins derived from two forms of vitellogenin are differentially processed during oocyte maturation in haddock (Melanogrammus aeglefinus).
M. Reith
,
J. Munholland
,
J. Kelly
,
R. N. Finn
,
H. J. Fyhn
The Journal of experimental zoology
2001
Corpus ID: 19130500
In the process of cloning vitellogenin (Vtg) cDNAs from haddock (Melanogrammus aeglefinus), two related, but distinct, mRNAs were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE